BARRERA, Giuseppina
 Distribuzione geografica
Continente #
NA - Nord America 7.708
EU - Europa 5.536
AS - Asia 2.867
AF - Africa 101
SA - Sud America 52
OC - Oceania 29
Continente sconosciuto - Info sul continente non disponibili 14
Totale 16.307
Nazione #
US - Stati Uniti d'America 7.555
IT - Italia 1.969
CN - Cina 1.777
SE - Svezia 639
IE - Irlanda 560
DE - Germania 512
FR - Francia 380
UA - Ucraina 306
FI - Finlandia 280
GB - Regno Unito 263
KR - Corea 252
SG - Singapore 196
VN - Vietnam 149
PL - Polonia 142
AT - Austria 140
CA - Canada 138
JP - Giappone 124
IN - India 107
TW - Taiwan 95
BE - Belgio 52
NL - Olanda 49
SN - Senegal 48
DK - Danimarca 36
HK - Hong Kong 34
ES - Italia 33
RU - Federazione Russa 32
BR - Brasile 31
AU - Australia 28
IR - Iran 23
TR - Turchia 23
CH - Svizzera 19
GR - Grecia 19
ET - Etiopia 17
CZ - Repubblica Ceca 15
ID - Indonesia 15
MX - Messico 14
PT - Portogallo 14
RO - Romania 14
EU - Europa 13
HR - Croazia 13
TH - Thailandia 11
BY - Bielorussia 10
MU - Mauritius 10
SA - Arabia Saudita 9
HU - Ungheria 8
PH - Filippine 8
UZ - Uzbekistan 8
EG - Egitto 7
RS - Serbia 7
ZA - Sudafrica 7
AR - Argentina 6
BG - Bulgaria 6
CO - Colombia 6
DZ - Algeria 6
IQ - Iraq 6
IL - Israele 5
MY - Malesia 5
CL - Cile 4
PK - Pakistan 4
SI - Slovenia 4
LB - Libano 3
MK - Macedonia 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
KE - Kenya 2
LK - Sri Lanka 2
MO - Macao, regione amministrativa speciale della Cina 2
NO - Norvegia 2
PE - Perù 2
A1 - Anonimo 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BT - Bhutan 1
EC - Ecuador 1
EE - Estonia 1
LU - Lussemburgo 1
LV - Lettonia 1
MA - Marocco 1
MN - Mongolia 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
OM - Oman 1
QA - Qatar 1
UY - Uruguay 1
ZM - Zambia 1
ZW - Zimbabwe 1
Totale 16.307
Città #
Chandler 1.110
Beijing 992
Dublin 554
Torino 537
Houston 494
Fairfield 459
Ashburn 407
Jacksonville 307
Ann Arbor 290
Villeurbanne 239
Woodbridge 232
Dearborn 224
Nyköping 213
Wilmington 213
Medford 187
Seattle 184
Princeton 175
Cambridge 159
Redwood City 151
Vienna 135
Warsaw 123
Singapore 117
Pisa 115
Milan 112
Dong Ket 110
Shanghai 94
Fremont 89
Taipei 70
Turin 68
Nanjing 62
Boardman 61
Toronto 61
New York 59
Rome 59
Guangzhou 55
Boston 48
Verona 43
Brussels 39
Washington 37
Hefei 36
San Diego 35
Los Angeles 34
Chengdu 33
Munich 31
Shenyang 30
Napoli 28
Hangzhou 26
Jinan 26
Changsha 24
Falls Church 23
Helsinki 23
Kunming 23
Lachine 23
Xian 22
Wuhan 21
Düsseldorf 20
Norwalk 20
Tianjin 20
Tokyo 19
Phoenix 18
Silver Spring 16
Zhengzhou 16
Cincinnati 15
Florence 15
Seoul 15
Serra 15
Bologna 14
Parma 14
Hebei 13
London 13
Nanchang 13
Bari 12
Catania 12
Chicago 12
Palermo 12
Amsterdam 11
Detroit 11
Montréal 11
Athens 10
Auburn Hills 10
Chongqing 10
Ottawa 10
Fuzhou 9
Gloucester 9
Gravina In Puglia 9
Groningen 9
Hong Kong 9
Monmouth Junction 9
Mountain View 9
Mumbai 9
Baotou 8
Duncan 8
Genova 8
Pune 8
São Paulo 8
Berlin 7
Dallas 7
Delhi 7
Edinburgh 7
Frankfurt am Main 7
Totale 9.646
Nome #
Effetti del 4-idrossinonenale, un’aldeide prodotta dalla perossidazione lipidica, sull’espressione dei microRNA in cellule leucemiche umane HL-60 883
Role of 4-Hydroxynonenal-Protein Adducts in Human Diseases. 851
Crosstalk between Nrf2 and YAP contributes to maintaining the antioxidant potential and chemoresistance in bladder cancer 617
Drug delivery nanoparticles in treating chemoresistant tumor cells 385
GSH-targeted nanosponges increase doxorubicin-induced toxicity "in vitro" and "in vivo" in cancer cells with high antioxidant defenses 320
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 319
Post-translational inhibition of YAP oncogene expression by 4-hydroxynonenal in bladder cancer cells 254
Immunotargeting of antigen xCT attenuates stem-like cell behavior and metastatic progression in breast cancer 246
Combination strategy targeting VEGF and HGF/c-met in human renal cell carcinoma models. 240
Drug Delivery Nanoparticles in Skin Cancers 218
Solid lipid nanoparticles of cholesteryl butyrate inhibit the proliferation of cancer cells in vitro and in vivo models. 196
KRIT1 loss-of-function induces a chronic Nrf2-mediated adaptive homeostasis that sensitizes cells to oxidative stress: Implication for Cerebral Cavernous Malformation disease 195
YAP activation protects urothelial cell carcinoma from treatment-induced DNA damage 193
The inclusion complex of 4-hydroxynonenal with a polymeric derivative of Β-cyclodextrin enhances the antitumoralefficacyof the aldehyde in several tumor cell lines and in a three-dimensional human melanoma model 191
Ailanthone inhibits cell growth and migration of cisplatin resistant bladder cancer cells through down-regulation of Nrf2, YAP, and c-Myc expression 189
Cholesteryl butyrate solid lipid nanoparticles inhibit the adhesion and migration of colon cancer cells. 188
3D advanced human melanoma models 183
null 181
Nanosponge-encapsulated camptothecin exerts anti-tumor activity in human prostate cancer cells 176
Mitochondrial Dysfunction in Cancer and Neurodegenerative Diseases: Spotlight on Fatty Acid Oxidation and Lipoperoxidation Products 163
AS601245, an anti-inflammatory JNK inhibitor, and clofibrate have a synergistic effect in inducing cell responses and in affecting the gene expression profile, in CaCo-2 colon cancer cells. 162
Effetti del 4-idrossinonenale, un prodotto della per ossidazione lipidica, sull’espressione e l’attività dell’enzima telomerasi in cellule leucemiche umane 157
Interaction of aldehydes derived from lipid peroxidation and membrane proteins. 153
Rosiglitazone and AS601245 Decrease Cell Adhesion and Migration through Modulation of Specific Gene Expression in Human Colon Cancer Cells 153
4-hydroxynonenal and cell cycle 152
The Potential Therapeutic Target Nrf2 in Childhood Brain Tumors 146
3D advanced melanoma models 143
Generation of Adducts of 4-Hydroxy-2-nonenal with Heat Shock 60 kDa Protein 1 in Human Promyelocytic HL-60 and Monocytic THP-1 Cell Lines 140
Oxidative Stress and Lipid Peroxidation Products in Cancer Progression and Therapy 136
In Vitro Modeling of Tissue-Specific 3D Microenvironments and Possibile Application to Pediatric Cancer Research 133
AS601245, an Anti-Inflammatory JNK Inhibitor, Strengthens the Effects of Clofibrate and Affects Gene Expression Profile, in CaCo-2 Colon Cancer Cells 133
Induction of differentiation in human HL-60 cells by 4-hydroxynonenal, a product of lipid peroxidation. 132
Low-dose curcuminoid-loaded in dextran nanobubbles can prevent metastatic spreading in prostate cancer cells 130
Pathology and physiology of lipi peroxidation and its carbonyl producs 122
Synergistic effect of 4-hydroxynonenal and PPAR ligands in controlling human leukemic cell growth and differentiation. 121
4-idrossinonenale: un regolatore endogeno del potenziale replicativi delle cellule 120
PPARy in coronary atherosclerosis: In vivo expression pattern and correlations with hyperlipidemic status and statin treatment 120
Lipid peroxidation in colorectal carcinogenesis: bad and good news 117
B7h Triggering Inhibits Umbilical Vascular Endothelial Cell Adhesiveness to Colon Carcinoma Cell Lines and Polymorphonuclear Cells. 110
[Changes in adenosinetriphosphatase activity in rat liver after CC14 poisoning] 109
In Vitro and In Vivo Therapeutic Evaluation of Camptothecin-Encapsulated β-Cyclodextrin Nanosponges in Prostate Cancer 108
Effect of Camptothecin nanosponges on anaplastic thyroid cancer models 104
Effect of 4-hydroxynonenal on c-myc expression. 103
Residual latent activity of acid phosphatase in total rat liver homogenate: a parameter for autophagy? 103
Are the catecholestrogens involved in estrogen-induced striatal dopamine receptor supersensitivity? 102
4-Hydroxy-2,3-nonenal as a signal for cell function and differentiation. 102
4-Hydroxynonenal as a biological signal: molecular basis and pathophysiological implications. 102
Cholesteryl butyrate solid lipid nanoparticles inhibit adhesion and migration of colon cancer cells 101
Endothelial Cell Adhesiveness to Colon Carcinoma Cell Lines and Polymorphonuclear Cells 101
Peroxisome proliferator-activated receptor ligands affect growth-related gene expression in human leukemic cells. 101
Structure-activity relationships of calmodulin antagonism by triphenylethylene antiestrogens. 100
DNA damage by lipid peroxidation products: implications in cancer, inflammation and autoimmunity 100
Glutathione-responsive cyclodextrin-nanosponges as drug delivery systems for doxorubicin: Evaluation of toxicity and transport mechanisms in the liver 98
The "Two-Faced" Effects of Reactive Oxygen Species and the Lipid Peroxidation Product 4-Hydroxynonenal in the Hallmarks of Cancer 97
Lipid peroxidation-derived aldehydes, 4-hydroxynonenal and malondialdehyde in aging-related disorders 96
4-Hydroxynonenal and PPARgamma ligands affect proliferation, differentiation, and apoptosis in colon cancer cells 95
4-hydroxynonenal specifically inhibits c-myb but does not affect c-fos expressions in HL-60 cells. 95
4-Hydroxynonenal modulation of p53 family gene expression in the SK-N-BE neuroblastoma cell line 94
Subcellular calmodulin distribution in rat liver after CCl4 poisoning. 93
Residual latent activity of acid phosphatase: autophagy-related variations and effects of cycloheximide. 93
Improved Anti-Tumoral Therapeutic Efficacy of 4-Hydroxynonenal Incorporated in Novel Lipid Nanocapsules in 2D and 3D Models 93
Latest News on Nanotechnology for Melanoma Therapy and Diagnosis 93
Rosiglitazone, Alone or in Combination with AS601245, an Anti-Inflammatory JNK Inhibitor, Affects Apoptosis, Differentiation and Cell Adhesion in CaCo-2 Human Colon Cancer Cells Through Modulation of Specific Gene Expressions. 93
Camptothecin in nanosponges as new therapeutic delivery agent in prostate cancer: in vitro and in vivo evaluation 92
Paclitaxel-Loaded Nanosponges Inhibit Growth and Angiogenesis in Melanoma Cell Models 92
Cellular distribution of lysosomal hydrolase activities in the regenerating rat liver. 91
Identification of 4-Hydroxynonenal-alpha-enolase adducts in HL-60 human leukemic cells: inhibition of plasminogen binding 90
Azione citotossica in vitro del colesterilbutirrato incorporato in nanoparticelle lipidiche solide 90
B7h triggering inhibits umbilical vascular endothelial cell adhesiveness to tumor cell lines and polymorphonuclear cells 90
Acid phosphatase residual latent activity versus lysosome osmotic fragility in rat liver autophagy. 87
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in orthotopic xenograft tumors in vivo 86
Effect of methylglyoxal on rat liver lysosome-vacuolar apparatus. 85
Calmodulin antagonism and growth-inhibiting activity of triphenylethylene antiestrogens in MCF-7 human breast cancer cells. 84
Nuclear factor erythroid 2-related factor-2 activity controls 4-hydroxynonenal metabolism and activity in prostate cancer cells. 84
Effect of Epomediol on the ATPase and adenylate cyclase activities in plasmamembranes isolated from rat liver. 83
Cholesteryl butyrate solid lipid nanoparticles as a butyric acid pro-drug: effects on cell proliferation, cell-cycle distribution and c-myc expression in human leukemic cells 81
Control of oxidative stress in cancer chemoresistance: spotlight on Nrf2 role 81
4-Hydroxynonenal inhibits telomerase activity and hTERT expression in human leukemic cell lines 80
PPARgamma ligands inhibit telomerase activity and hTERT expression through modulation of the Myc/Mad/Max network, in colon cancer cells 80
Decreased osmotic fragility of rat liver lysosomes after cycloheximide treatment. 79
4-hydroxynonenal and regulation of cell cycle: effects on the pRb/E2F pathway 79
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 79
MicroRNA expression profiling during human leukemic HL-60 cell differentiation induced by 4-Hydroxynonenal, a product of lipid peroxidation 77
Effect of fasting and glucagon on the residual latent activity of acid phosphatase in rat liver. 77
Induction of cell cycle arrest and DNA damage by the HDAC inhibitor panobinostat (LBH589) and the lipid peroxidation end product 4-hydroxynonenal in prostate cancer cells. 77
Challangers and Opportunities of Nanoparticle-Based Theranostics in Skin Cancer 77
Improvement in the anti-tumor efficacy of doxorubicin nanosponges in in vitro and in mice bearing breast tumor models 76
Carbosilane dendrimers loaded with sirna targeting nrf2 as a tool to overcome cisplatin chemoresistance in bladder cancer cells 76
Lysis of rat liver lysosomes through incubation with 1-leucyl-glycine, substrate for a lysosomal dipeptidase. 75
4-Hydroxynonenal, a product of cellular lipid peroxidation, which modulates c-myc and globin gene expression in K562 erythroleukemic cells. 75
Ruolo svolto dai prodotti della perossidazione lipidica e dai ligandi di PPAR sul controllo della crescita di cellule di carcinoma del colon 75
Glutathione Bioresponsive Cyclodextrin Nanosponges 75
Effects of 4-hydroxynonenal on adenylate cyclase and 5'-nucleotidase activities in rat liver plasma membranes. 74
Enzymatic pattern of aldehyde metabolism during HL-60 cell differentiation. 74
4-hydroxynonenal effects on telomerase activity and expression in leukemic cells 74
4-Hydroxynonenal: an endogenous signal for cell proliferation and differentiation. 72
4-hydroxynonenal affects the proliferation and the apoptosis in SK-N-BE neuroblastoma cell line 72
4-Hydroxynonenal (HNE), a product of lipide peroxidation, inhibits telomerase activity in Caco-2, a colon cancer cell line, by the inhibition of E-Box activity of the h-TERT promoter 72
Cytotoxic effect of Camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo in orthotopic xenograft tumors 71
Effetto del 4-idrossinonenale su alcuni meccanismi della proliferazione cellulare. 70
Totale 14.096
Categoria #
all - tutte 41.745
article - articoli 0
book - libri 0
conference - conferenze 9.061
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 50.806


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.550 132 119 146 224 183 430 323 218 272 224 157 122
2020/20212.086 169 130 152 150 186 152 154 109 288 165 168 263
2021/20221.908 96 99 72 124 88 61 116 85 96 158 502 411
2022/20232.976 293 255 61 364 247 745 176 202 300 92 142 99
2023/20241.537 187 216 122 107 101 187 82 123 12 102 132 166
2024/202532 32 0 0 0 0 0 0 0 0 0 0 0
Totale 16.856